Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan J Mathis

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Pharmaceutics|September 28, 2021
Gold Nanoparticles Permit In Situ Absorbed Dose Evaluation in Boron Neutron Capture Therapy for Malignant TumorsAlexander Zaboronok, Sergey Taskaev, Olga Volkova, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 24, 2022
Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumorsTakashi Kawahara, Koji Kawai, Takahiro Kojima, et al.
BMC Cancer|March 14, 2025
Long term survival in elderly patients with resectable upper tract urothelial carcinoma: analysis of hospital-based cancer registry data in JapanShuhei Suzuki, Yoshiyuki Nagumo, Kosuke Kojo, et al.
World Journal of Surgical Oncology|October 1, 2025
Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancerOsamu Shimomura, Haruko Numajiri, Shinji Hashimoto, et al.
Scientific Reports|December 18, 2023
Natto consumption suppresses atherosclerotic plaque progression in LDL receptor-deficient mice transplanted with iRFP-expressing hematopoietic cellsTakeshi Kawamata, Arata Wakimoto, Takanobu Nishikawa, et al.
Ejhaem|December 18, 2024
Association between microenvironment-related genes and prognosis of primary central nervous system lymphomaKeiichiro Hattori, Kenichi Makishima, Sakurako Suma, et al.
The Oncologist|February 18, 2026
Novel antiemetic effect of naldemedine in patients initiating opioids for cancer pain: A secondary analysis of a randomized clinical trialTakahiro Higashibata, Takaomi Kessoku, Shinya Kajiura, et al.
European Urology|January 18, 2026
Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 TrialYoshiyuki Nagumo, Tomokazu Kimura, Hitoshi Ishikawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialJun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
BMC Cancer|July 4, 2023
Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer: a phase I/II study protocol (TT-LAP trial)Osamu Shimomura, Masato Endo, Hirokazu Makishima, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Pharmaceutics|September 28, 2021
Gold Nanoparticles Permit In Situ Absorbed Dose Evaluation in Boron Neutron Capture Therapy for Malignant TumorsAlexander Zaboronok, Sergey Taskaev, Olga Volkova, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 24, 2022
Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumorsTakashi Kawahara, Koji Kawai, Takahiro Kojima, et al.
BMC Cancer|March 14, 2025
Long term survival in elderly patients with resectable upper tract urothelial carcinoma: analysis of hospital-based cancer registry data in JapanShuhei Suzuki, Yoshiyuki Nagumo, Kosuke Kojo, et al.
World Journal of Surgical Oncology|October 1, 2025
Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancerOsamu Shimomura, Haruko Numajiri, Shinji Hashimoto, et al.
Scientific Reports|December 18, 2023
Natto consumption suppresses atherosclerotic plaque progression in LDL receptor-deficient mice transplanted with iRFP-expressing hematopoietic cellsTakeshi Kawamata, Arata Wakimoto, Takanobu Nishikawa, et al.
Ejhaem|December 18, 2024
Association between microenvironment-related genes and prognosis of primary central nervous system lymphomaKeiichiro Hattori, Kenichi Makishima, Sakurako Suma, et al.
The Oncologist|February 18, 2026
Novel antiemetic effect of naldemedine in patients initiating opioids for cancer pain: A secondary analysis of a randomized clinical trialTakahiro Higashibata, Takaomi Kessoku, Shinya Kajiura, et al.
European Urology|January 18, 2026
Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 TrialYoshiyuki Nagumo, Tomokazu Kimura, Hitoshi Ishikawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialJun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
BMC Cancer|July 4, 2023
Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer: a phase I/II study protocol (TT-LAP trial)Osamu Shimomura, Masato Endo, Hirokazu Makishima, et al.
Pageof 15